Sales under the Chip Foundation co-development agreement are expected to continue throughout 2025 MANCHESTER, England, Jan. 16, 2025 /PRNewswire/ -- Smartkem (Nasdaq: SMTK), which is seeking ...
Smartkem (Nasdaq: SMTK), which is seeking to change the world of electronics using its disruptive organic thin-film transistors (OTFTs), announced that it has completed the first sale of its TRUFLEX® ...
VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...
11 (Xinhua) -- Indonesia's entry into BRICS marks a strategic milestone for its domestic economy and global trade landscape ... This reflects the BRICS principle of fostering cooperation in economic ...
Port City Colombo celebrated a milestone today with the groundbreaking of the Marina Development, a joint venture between Browns Investments PLC, the strategic investment arm of LOLC Group and ...
Bio-Path also expects to utilize an advisory panel of AML experts to assist in the design of the final clinical development plans through potential FDA approval. Other significant milestones ...
"Our growth in 2024 and our planned portfolio expansion has validated Xentria as a trusted partner for challenging drug development. This celebration of milestones is due to the incredible cross ...